Advanced Polymer Materials to
Cure Inflammatory Diseases
When Inflammation Gets Out of Control
Inflammation is the body’s natural response to tissue damage and infection. In many chronic conditions, it becomes uncontrolled and drives diseases ranging from non-healing wounds to systemic disorders.
Our ResCure® technology is based on unique polymer materials that dampen uncontrolled inflammation and enable healing by binding and neutralizing inflammatory cytokines through programmed affinity. This paves the way for effective treatment of inflammation-driven diseases.
As part of a technology transfer funded by the European Union, ResCure® acquired technological expertise and the associated property rights for inflammation-resolving polymer materials. Based on this, it is developing innovative medical devices for the treatment of inflammatory diseases.
Transforming Inflammatory Disease Treatment Through Polymer Material Innovation
We’re pioneering a revolutionary platform technology that targets inflammation across multiple disease areas, offering a new paradigm for treating chronic and inflammation-driven conditions.
Therapeutic Mechanism
ResCure® works by physically binding multiple inflammatory cytokines, while leaving regenerative factors largely unaffected. From chronic wounds to systemic diseases, it enables effective therapies.
Drug-Free
Our technology delivers its effect through the polymer matrix itself, without the use of drugs or bioactives. This unique mode of action represents a completely new way of addressing inflammation-driven diseases.
Platform Technology
The affinity profile can be precisely tuned to target different diseases. Versatile processing options allow the application of our material across a range of different formats, such as coatings, powders, and gels.
Our Applications
Our first product focuses on chronic wounds, while additional indications are in development.
ResCure® Dressing
ResCure® Dressing is being developed for the management of chronic, non-healing wounds, such as venous leg ulcers (Ulcus cruris venosum).
It is a drug-free wound contact layer with a specialized polymer coating designed to bind and remove excessive inflammatory cytokines from the wound environment. Safety and efficiency of ResCure® Dressing are currently being evaluated in a multi-centric, randomized controlled clinical trial in patients with chronic venous leg ulcers.
The ongoing evaluation is being conducted in wound care centers in Germany. For details please check the German Clinical Trials Register ID: DRKS00034340
About us
ResCure® GmbH is a spin-off of the Leibniz Institute of Polymer Research Dresden. We combine expertise in the design and manufacturing of inflammation-resolving polymer materials and their translation into medical devices.
Our multidisciplinary team includes specialists in polymer synthesis, cell biology, biomedical and chemical engineering, quality management, regulatory affairs, business development, and accounting, to turn innovative materials into clinically relevant solutions.
Our journey began with an EXIST research transfer project funded by the German Federal Ministry for Economic Affairs and Energy (BMWE). In 2024, ResCure® won the Science4Life business plan competition, highlighting the potential of our technology.
